Michael Xiang News Today

Learn about disparities in the use of second-generation androgen receptor inhibitors for prostate cancer and how to improve outcomes.

Highlights from CBC News, The Guardian, Reuters and others.

Black men with advanced prostate cancer less likely to receive crucial treatment, study finds. UCLA-led study shows Black men are 24% less likely to be prescribed novel hormone therapy compared to white men.

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

A nomogram provides indirect evidence of the power of PSMA PET/CT imaging.

The probability of nonlocalized upstaging on PSMA PET/CT may be prognostic of long-term outcomes in high-risk prostate cancer.

The probability of nonlocalized upstaging on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) may be prognostic of long-term outcomes in high-risk prostate cancer.